Stockholders' Equity	12 Months Ended
Dec. 31, 2024
Stockholders' Equity
Stockholders' Equity	11. Stockholders’ Equity Common Stock Authorized and Outstanding As of December 31, 2024, the Company has 700,000,000 shares of common stock authorized for issuance and 85,950,493 shares of common stock issued and outstanding. Preferred Stock Authorized and Outstanding As of December 31, 2024, the Company has 100,000,000 shares of preferred stock authorized for issuance and no shares of preferred stock issued and outstanding. Outstanding Warrants As of December 31, 2024, there were outstanding warrants to purchase an aggregate of 2,000,000 shares of common stock at an exercise price of $20.00 per share (subject to adjustment). The outstanding warrants are exercisable through July 10, 2027.

The entire disclosure for the formation, structure, control and ownership of the partnership. Disclosures related to accounts comprising partners' capital. Includes balances of general partners' capital account, limited partners' capital account, preferred partners' capital account and total partners' capital account and units outstanding; accumulated other comprehensive income; amount and nature of changes to amount of partner's capital and units outstanding by class, rights and privileges for each class of units; distribution policies and distributions paid by unit class; impact of and correction of an error in previously issued financial statements; limitations of partners' liability; redemption, conversion and distribution policies; and deferred compensation related to the issuance of units.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Name:	us-gaap_PartnersCapitalNotesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration